{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:36:27Z","timestamp":1790487387046,"version":"4.1.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Virology Branch, National Institute of Allergic and Infectious Diseases, National Institutes of Health","award":["N01-AI-15435"],"award-info":[{"award-number":["N01-AI-15435"]}]},{"name":"Virology Branch, National Institute of Allergic and Infectious Diseases, National Institutes of Health","award":["HHSN272201000039I\/HHSN27200002\/A14"],"award-info":[{"award-number":["HHSN272201000039I\/HHSN27200002\/A14"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.antiviral.2016.12.007","type":"journal-article","created":{"date-parts":[[2016,12,9]],"date-time":"2016-12-09T22:01:29Z","timestamp":1481320889000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Prophylactic and therapeutic intranasal administration with an immunomodulator, Hiltonol\u00ae (Poly IC:LC), in a lethal SARS-CoV-infected BALB\/c mouse model"],"prefix":"10.1016","volume":"139","author":[{"given":"Yohichi","family":"Kumaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres M.","family":"Salazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles K.","family":"Wandersee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4505-020X","authenticated-orcid":false,"given":"Dale L.","family":"Barnard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2016.12.007_bib1","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1126\/science.1069132","article-title":"RNA-dependent RNA polymerases, viruses, and RNA silencing","volume":"296","author":"Ahlquist","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2016.12.007_bib2","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2016.12.007_bib3","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3","volume":"413","author":"Alexopoulou","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2016.12.007_bib4","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1126\/science.1085658","article-title":"Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs","volume":"300","author":"Anand","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2016.12.007_bib5","doi-asserted-by":"crossref","first-page":"17264","DOI":"10.1073\/pnas.0407639101","article-title":"The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter","volume":"101","author":"Andrejeva","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.12.007_bib6","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/infdis\/136.2.286","article-title":"Successful prophylaxis against rabies in mice and Rhesus monkeys: the interferon system and vaccine","volume":"136","author":"Baer","year":"1977","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.12.007_bib7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/095632020601700505","article-title":"Evaluation of immunomodulators, interferons and known in\u00a0vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB\/c mice","volume":"17","author":"Barnard","year":"2006","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.antiviral.2016.12.007_bib8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.antiviral.2006.03.001","article-title":"Enhancement of the infectivity of SARS-CoV in BALB\/c mice by IMP dehydrogenase inhibitors, including ribavirin","volume":"71","author":"Barnard","year":"2006","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.12.007_bib9","series-title":"Antiviral Research: Strategies in Antiviral Drug Discovery","first-page":"209","article-title":"Development in the search for the small-molecule inhibitors for treatment of severe acute respiratory syndrome coronavirus","author":"Barnard","year":"2009"},{"key":"10.1016\/j.antiviral.2016.12.007_bib10","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1001\/jama.289.21.JOC30885","article-title":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area","volume":"289","author":"Booth","year":"2003","journal-title":"Jama"},{"key":"10.1016\/j.antiviral.2016.12.007_bib11","doi-asserted-by":"crossref","first-page":"8455","DOI":"10.1073\/pnas.0400576101","article-title":"Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides","volume":"101","author":"Bosch","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.12.007_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2165\/00063030-200721010-00002","article-title":"Therapeutic and prophylactic potential of small interfering RNAs against severe acute respiratory syndrome: progress to date","volume":"21","author":"Chang","year":"2007","journal-title":"BioDrugs"},{"key":"10.1016\/j.antiviral.2016.12.007_bib13","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev.immunol.25.022106.141706","article-title":"The immunobiology of SARS*","volume":"25","author":"Chen","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2016.12.007_bib14","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/S0140-6736(03)13615-X","article-title":"Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus","volume":"361","author":"Cinatl","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2016.12.007_bib15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0952-7915(02)00349-7","article-title":"Interferon-producing cells: on the front line in immune responses against pathogens","volume":"14","author":"Colonna","year":"2002","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.antiviral.2016.12.007_bib16","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.virol.2009.09.023","article-title":"A\u00a0new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in\u00a0vitro and in\u00a0vivo","volume":"395","author":"Day","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.12.007_bib17","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nature01783","article-title":"Viral infection switches non-plasmacytoid dendritic cells into high interferon producers","volume":"424","author":"Diebold","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2016.12.007_bib18","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa030747","article-title":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome","volume":"348","author":"Drosten","year":"2003","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.antiviral.2016.12.007_bib19","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ni921","article-title":"IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway","volume":"4","author":"Fitzgerald","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.antiviral.2016.12.007_bib20","first-page":"507","article-title":"Antisense DNA and RNA strategies: new approaches to therapy","volume":"28","author":"Gibson","year":"1994","journal-title":"J.\u00a0R. Coll. Phys. Lond."},{"key":"10.1016\/j.antiviral.2016.12.007_bib21","doi-asserted-by":"crossref","first-page":"6301","DOI":"10.4049\/jimmunol.177.9.6301","article-title":"TLR3 deletion limits mortality and disease severity due to Phlebovirus infection","volume":"177","author":"Gowen","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2016.12.007_bib22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1165\/rcmb.2003-0315TR","article-title":"Molecular mechanisms of pulmonary peptidomimetic drug and peptide transport","volume":"30","author":"Groneberg","year":"2004","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.antiviral.2016.12.007_bib23","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1053\/rmed.2002.1457","article-title":"Fundamentals of pulmonary drug delivery","volume":"97","author":"Groneberg","year":"2003","journal-title":"Respir. Med."},{"key":"10.1016\/j.antiviral.2016.12.007_bib24","doi-asserted-by":"crossref","first-page":"10190","DOI":"10.1128\/JVI.79.16.10190-10199.2005","article-title":"Activity and regulation of alpha interferon in respiratory syncytial virus and human metapneumovirus experimental infections","volume":"79","author":"Guerrero-Plata","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.12.007_bib25","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.4269\/ajtmh.1977.26.1191","article-title":"Intranasal infection of monkeys with Japanese encephalitis virus: clinical response and treatment with a nuclease-resistant derivative of poly (I).poly (C)","volume":"26","author":"Harrington","year":"1977","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2016.12.007_bib26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/08830189809042997","article-title":"Interleukin 6 and its receptor: ten years later","volume":"16","author":"Hirano","year":"1998","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2016.12.007_bib27","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1164\/rccm.200306-766OC","article-title":"High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome","volume":"168","author":"Ho","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.antiviral.2016.12.007_bib28","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.antiviral.2005.10.005","article-title":"Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction","volume":"69","author":"Ho","year":"2006","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.12.007_bib29","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nature01889","article-title":"Identification of Lps2 as a key transducer of MyD88-independent TIR signalling","volume":"424","author":"Hoebe","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2016.12.007_bib30","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1126\/science.1132505","article-title":"5'-Triphosphate RNA is the ligand for RIG-I","volume":"314","author":"Hornung","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2016.12.007_bib31","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1128\/JVI.79.5.2910-2919.2005","article-title":"Synthetic double-stranded RNA poly(I: C) combined with mucosal vaccine protects against influenza virus infection","volume":"79","author":"Ichinohe","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.12.007_bib32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cell.2008.02.043","article-title":"Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury","volume":"133","author":"Imai","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2016.12.007_bib33","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1098\/rspb.1957.0048","article-title":"Virus interference. I. The interferon","volume":"147","author":"Isaacs","year":"1957","journal-title":"Proc. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.antiviral.2016.12.007_bib34","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1098\/rspb.1957.0049","article-title":"Virus interference. II. Some properties of interferon","volume":"147","author":"Isaacs","year":"1957","journal-title":"Proc. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.antiviral.2016.12.007_bib35","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1164\/rccm.200407-857OC","article-title":"Characterization of cytokine\/chemokine profiles of severe acute respiratory syndrome","volume":"171","author":"Jiang","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.antiviral.2016.12.007_bib36","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2174\/1389450013348245","article-title":"Gene therapy: optimising DNA delivery to the nucleus","volume":"2","author":"Johnson-Saliba","year":"2001","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.antiviral.2016.12.007_bib37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature04734","article-title":"Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses","volume":"441","author":"Kato","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2016.12.007_bib38","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1128\/AAC.31.7.986","article-title":"Enhanced therapeutic efficacy of poly(ICLC) and ribavirin combinations against Rift Valley fever virus infection in mice","volume":"31","author":"Kende","year":"1987","journal-title":"Antimicrob. agents Chemother."},{"key":"10.1016\/j.antiviral.2016.12.007_bib39","doi-asserted-by":"crossref","first-page":"8946","DOI":"10.1128\/JVI.01857-08","article-title":"Toll-like receptor 4 deficiency increases disease and mortality after mouse hepatitis virus type 1 infection of susceptible C3H mice","volume":"83","author":"Khanolkar","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.12.007_bib40","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1128\/JVI.01782-06","article-title":"Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists","volume":"81","author":"Kopecky-Bromberg","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.12.007_bib41","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa030781","article-title":"A\u00a0novel coronavirus associated with severe acute respiratory syndrome","volume":"348","author":"Ksiazek","year":"2003","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.antiviral.2016.12.007_bib42","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3851\/IMP1477","article-title":"Induction of interferon-gamma-inducible protein 10 by SARS-CoV infection, interferon alfacon 1 and interferon inducer in human bronchial epithelial Calu-3 cells and BALB\/c mice","volume":"20","author":"Kumaki","year":"2010","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.antiviral.2016.12.007_bib44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.antiviral.2010.11.007","article-title":"Single-dose intranasal administration with mDEF201 (adenovirus vectored mouse interferon-alpha) confers protection from mortality in a lethal SARS-CoV BALB\/c mouse model","volume":"89","author":"Kumaki","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.12.007_bib45","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.antiviral.2011.02.003","article-title":"Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB\/c mouse model by stinging nettle lectin, Urtica dioica agglutinin","volume":"90","author":"Kumaki","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.12.007_bib46","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/sj.gt.3302645","article-title":"Antiviral RNAi therapy: emerging approaches for hitting a moving target","volume":"13","author":"Leonard","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.antiviral.2016.12.007_bib47","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/infdis\/132.4.434","article-title":"A\u00a0modified polyriboinosinic-polyribocytidylic acid complex that induces interferon in primates","volume":"132","author":"Levy","year":"1975","journal-title":"J.\u00a0Infect. Dis."},{"issue":"Suppl","key":"10.1016\/j.antiviral.2016.12.007_bib48","doi-asserted-by":"crossref","first-page":"A256","DOI":"10.1093\/infdis\/133.Supplement_2.A256","article-title":"Prophylactic control of simian hemorrhagic fever in monkeys by an interferon inducer, polyriboinosinic-polyribocytidylic acid-poly-L-lysine","volume":"133","author":"Levy","year":"1976","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.12.007_bib49","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1128\/MCB.18.5.2986","article-title":"Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation","volume":"18","author":"Lin","year":"1998","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.antiviral.2016.12.007_bib50","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.1093\/emboj\/17.22.6660","article-title":"Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7","volume":"17","author":"Marie","year":"1998","journal-title":"Embo J."},{"key":"10.1016\/j.antiviral.2016.12.007_bib51","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1128\/JVI.00671-08","article-title":"Respiratory syncytial virus activates innate immunity through Toll-like receptor 2","volume":"83","author":"Murawski","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.12.007_bib52","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1189\/jlb.1103543","article-title":"Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system","volume":"75","author":"Netea","year":"2004","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.antiviral.2016.12.007_bib53","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0140-6736(03)13412-5","article-title":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study","volume":"361","author":"Peiris","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2016.12.007_bib54","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0140-6736(03)13077-2","article-title":"Coronavirus as a possible cause of severe acute respiratory syndrome","volume":"361","author":"Peiris","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2016.12.007_bib55","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1126\/science.1132998","article-title":"RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates","volume":"314","author":"Pichlmair","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2016.12.007_bib56","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1749-6632.1989.tb24028.x","article-title":"Regulation of expression of interleukin-6. Molecular and clinical studies","volume":"557","author":"Ray","year":"1989","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.antiviral.2016.12.007_bib57","first-page":"493","article-title":"A\u00a0simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"key":"10.1016\/j.antiviral.2016.12.007_bib58","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1073\/pnas.95.2.588","article-title":"A\u00a0family of human receptors structurally related to Drosophila Toll","volume":"95","author":"Rock","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.12.007_bib59","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.1085952","article-title":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome","volume":"300","author":"Rota","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2016.12.007_bib60","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1227\/00006123-199606000-00006","article-title":"Long-term treatment of malignant gliomas with intramuscularly administered polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethylcellulose: an open pilot study","volume":"38","author":"Salazar","year":"1996","journal-title":"Neurosurgery"},{"key":"10.1016\/j.antiviral.2016.12.007_bib61","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.4049\/jimmunol.171.8.4304","volume":"171","author":"Sato","year":"2003","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2016.12.007_bib62","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.4049\/jimmunol.162.6.3549","article-title":"The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells","volume":"162","author":"Sauty","year":"1999","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2016.12.007_bib63","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1084\/jem.167.6.1951","article-title":"Regulation of the acute phase and immune responses in viral disease. Enhanced expression of the beta 2-interferon\/hepatocyte-stimulating factor\/interleukin 6 gene in virus-infected human fibroblasts","volume":"167","author":"Sehgal","year":"1988","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.antiviral.2016.12.007_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1995.tb32309.x","article-title":"Interleukin-6-type cytokines","volume":"762","author":"Sehgal","year":"1995","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.antiviral.2016.12.007_bib65","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1126\/science.1081315","article-title":"Triggering the interferon antiviral response through an IKK-related pathway","volume":"300","author":"Sharma","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2016.12.007_bib66","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1159\/000239382","article-title":"In\u00a0vitro and in\u00a0vivo sensitivity of a non-mouse-adapted influenza A (Beijing) virus infection to amantadine and ribavirin","volume":"41","author":"Sidwell","year":"1995","journal-title":"Chemotherapy"},{"key":"10.1016\/j.antiviral.2016.12.007_bib67","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/jir.1994.14.101","article-title":"Fascination with 2-5A-dependent RNase: a unique enzyme that functions in interferon action","volume":"14","author":"Silverman","year":"1994","journal-title":"J.\u00a0Interferon Res."},{"key":"10.1016\/j.antiviral.2016.12.007_bib68","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1128\/JVI.79.4.2079-2086.2005","article-title":"Inhibition of Beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3","volume":"79","author":"Spiegel","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.12.007_bib69","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1743-422X-3-17","article-title":"Inhibition of cytokine gene expression and induction of chemokine genes in non-lymphatic cells infected with SARS coronavirus","volume":"3","author":"Spiegel","year":"2006","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2016.12.007_bib70","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/infdis\/136.1.122","article-title":"Effect of a nuclease-resistant derivative of polyriboinosinic-polyribocytidylic acid complex on yellow fever in rhesus monkeys (Macaca mulatta)","volume":"136","author":"Stephen","year":"1977","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.12.007_bib71","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1073\/pnas.0307140101","article-title":"Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association","volume":"101","author":"Sui","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.12.007_bib72","first-page":"179","article-title":"Severe acute respiratory syndrome: scientific and anecdotal evidence for drug treatment","volume":"5","author":"Tsang","year":"2004","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.antiviral.2016.12.007_bib73","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1056\/NEJMoa030666","article-title":"A\u00a0cluster of cases of severe acute respiratory syndrome in Hong Kong","volume":"348","author":"Tsang","year":"2003","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.antiviral.2016.12.007_bib74","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.3201\/eid0909.030362","article-title":"Severe acute respiratory syndrome: clinical outcome and prognostic correlates","volume":"9","author":"Tsui","year":"2003","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.12.007_bib75","doi-asserted-by":"crossref","first-page":"15319","DOI":"10.1074\/jbc.R700009200","article-title":"Toll-like receptors and Type I interferons","volume":"282","author":"Uematsu","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.12.007_bib76","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1128\/JVI.80.10.5059-5064.2006","article-title":"Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses","volume":"80","author":"Weber","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.12.007_bib77","doi-asserted-by":"crossref","first-page":"6112","DOI":"10.1038\/sj.onc.1203127","article-title":"PKR; a sentinel kinase for cellular stress","volume":"18","author":"Williams","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.antiviral.2016.12.007_bib78","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2249.2004.02415.x","article-title":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome","volume":"136","author":"Wong","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.antiviral.2016.12.007_bib79","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1016\/j.vaccine.2007.01.051","article-title":"Nucleic acid-based antiviral drugs against seasonal and avian influenza viruses","volume":"25","author":"Wong","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.12.007_bib80","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1128\/AAC.39.11.2574","article-title":"Prophylactic and therapeutic efficacies of poly(IC.LC) against respiratory influenza A virus infection in mice","volume":"39","author":"Wong","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.12.007_bib81","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/S0264-410X(98)00439-3","article-title":"Liposome-mediated immunotherapy against respiratory influenza virus infection using double-stranded RNA poly ICLC","volume":"17","author":"Wong","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.12.007_bib82","doi-asserted-by":"crossref","first-page":"e1494","DOI":"10.1371\/journal.pone.0001494","article-title":"Coronavirus spike protein inhibits host cell translation by interaction with eIF3f","volume":"3","author":"Xiao","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2016.12.007_bib83","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1126\/science.1087262","article-title":"Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway","volume":"301","author":"Yamamoto","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2016.12.007_bib84","doi-asserted-by":"crossref","first-page":"13190","DOI":"10.1073\/pnas.1835675100","article-title":"The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor","volume":"100","author":"Yang","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.12.007_bib85","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1128\/JVI.80.6.2684-2693.2006","article-title":"Modeling the early events of severe acute respiratory syndrome coronavirus infection in\u00a0vitro","volume":"80","author":"Yen","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.12.007_bib86","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ni1087","article-title":"The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses","volume":"5","author":"Yoneyama","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.antiviral.2016.12.007_bib87","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1128\/JVI.01792-08","article-title":"Severe acute respiratory syndrome (SARS) coronavirus-induced lung epithelial cytokines exacerbate SARS pathogenesis by modulating intrinsic functions of monocyte-derived macrophages and dendritic cells","volume":"83","author":"Yoshikawa","year":"2009","journal-title":"J.\u00a0Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216303850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216303850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T03:23:37Z","timestamp":1718940217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216303850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":86,"alternative-id":["S0166354216303850"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.12.007","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prophylactic and therapeutic intranasal administration with an immunomodulator, Hiltonol\u00ae (Poly IC:LC), in a lethal SARS-CoV-infected BALB\/c mouse model","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}